Dementia - Alzheimer Disease Market Size, Share, and Trends Analysis Report Size, Share, Trends, Growth Opportunities and Competitive Outlook 2030
" Dementia - Alzheimer Disease Market – Industry Trends and Forecast to 2030 Global Dementia - Alzheimer Disease Market, By Drug Class (Cholinergic/Cholinesterase (ChE) Inhibitors, Memantine , and Combined Drug), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Industry Trends and Forecast to 2030. Data Bridge Market Research analyses that the market, which was USD 13,000.00 million in 2022, would rocket up to USD 25,000.00 million by 2030 and is expected to undergo a CAGR of 8.5% during the forecast period. Cholinergic/Cholinesterase (ChE) inhibitors dominate the drug class segment of the Dementia - Alzheimer Disease market owing to the growing demand for chronic diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline...